Zevra Therapeutics ZVRA
NASDAQ ZVRA
$10.97 -0.37 (-3.26%)
At close: Sep 30, 2026 · 4:00 PM EDT

Zevra Therapeutics (ZVRA) Enterprise Value (2015 - 2026)

Updated

Zevra Therapeutics' Enterprise Value came in at $629.39 million for Q2 2026, up 122.7% from $282.68 million a year earlier and up 79.7% from the prior quarter.

Analysis

Zevra Therapeutics (ZVRA) Enterprise Value (2015 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Zevra Therapeutics reported Enterprise Value of $38.26 million, down 37.5% year-over-year; for FY2025, it came in at $318.41 million, down 15.8% from FY2024.

  • Enterprise Value carries a five-year compound annual growth rate of 26.7% (FY2020 to FY2025).
  • Going back by year, Enterprise Value was $378.12 million in FY2024 (+85.1%), $204.32 million in FY2023 (+168.2%), $76.17 million in FY2022 (-84.7%) and $497.45 million in FY2021 (+410.6%).
  • The Q2 2026 figure represents the highest quarterly Enterprise Value since Q2 2021.
  • Year-over-year, Enterprise Value increased in seven of the last eight quarters, with growth averaging 72.7%.
  • The fastest year-over-year change in Enterprise Value over five years came in Q3 2021 (growth of 588.0%), and the weakest in Q4 2022 (a decline of 84.7%).
  • Business Quant data shows ZVRA's Enterprise Value at $350.33 million (Q1 2026), $318.41 million (Q4 2025) and $335.12 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Zevra Therapeutics 672.94 Mn -139.77 Mn 38.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 629.39 Mn
Mar 31, 2026 350.33 Mn
Dec 31, 2025 318.41 Mn
Sep 30, 2025 335.12 Mn
Jun 30, 2025 282.68 Mn
Mar 31, 2025 346.92 Mn
Dec 31, 2024 378.12 Mn
Sep 30, 2024 280.02 Mn
Jun 30, 2024 156.50 Mn
Mar 31, 2024 190.02 Mn
Dec 31, 2023 204.32 Mn
Sep 30, 2023 91.60 Mn
Jun 30, 2023 86.14 Mn
Mar 31, 2023 111.77 Mn
Dec 31, 2022 76.17 Mn
Sep 30, 2022 354.68 Mn
Jun 30, 2022 226.67 Mn
Mar 31, 2022 244.72 Mn
Dec 31, 2021 497.45 Mn
Sep 30, 2021 527.52 Mn
API Access

Zevra Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=ZVRA&period=max&api_key=YOUR_API_KEY